Search

everythinglearnresearchcommunity

for

Search:↓

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

A specific signal from hair cells controls the tightening of the surrounding muscle, which is necessary for hair shedding.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hyperprolactinemia should be treated before confirming a PCOS diagnosis.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.